Please click here to obtain permission to reproduce this image.
Click on image to view larger version.
Figure 5 Comparison of event rates in the Thrombolysis In Myocardial Infarction (TIMI) IIIB versus Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy (TACTICS)-TIMI 18 trials stratified by TIMI risk score (TRS). ACS = acute coronary syndromes; CONS = conservative; Intermed = intermediate; INV = invasive; MI = myocardial infarction; Rehosp = rehospitalization. Reprinted with permission from Lippincott, Williams and Wilkins. Data from Sabatine MS, Cannon CP, Murphy SA, DiBattiste PM, Demopoulos LA, Braunwald E. Implications of upstream GP IIb/IIIa inhibition and stenting in the invasive management of UA/NSTEMI: a comparison of TIMI IIIB and TACTICS TIMI-18. Circulation 2001;104 Suppl II:II549.
|
